Inventor · disambiguated record
Maria Emilia Di Francesco
Also filed as: DI FRANCESCO MARIA E · DI FRANCESCO MARIA EMILIA
36 granted patents·13 pending applications·299 citations·filing 2002–2024
97Inventor score
Files withUNIV TEXAS29ALTMAN MICHAEL D5MERCK SHARP & DOHME4ANGELETTI P IST RICHERCHE BIO2BOARD OF REGENTS UNIV OF TEXAS SYSTEM2
Top patents by PatentIndex Score
49 records- 0196US11370786B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Jun 28, 2022·6 cites·17 claims
- 0295US11958849B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2022·Granted Apr 16, 2024·2 cites·12 claims
- 0394US10766892B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2019·Granted Sep 8, 2020·9 cites·26 claims
- 0494US7459452B2Dihydroxypyrimidine carboxamide inhibitors of HIV integraseANGELETTI P IST RICHERCHE BIO·Filed 2006·Granted Dec 2, 2008·22 cites·18 claims
- 0594US7232819B2Dihydroxypyrimidine carboxamide inhibitors of HIV integraseANGELETTI P IST RICHERCHE BIO·Filed 2002·Granted Jun 19, 2007·56 cites·46 claims
- 0693US9809588B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Granted Nov 7, 2017·15 cites·27 claims
- 0793US9006444B2Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted Apr 14, 2015·13 cites·10 claims
- 0892US10392376B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2018·Granted Aug 27, 2019·7 cites·32 claims
- 0992US10344025B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2017·Granted Jul 9, 2019·12 cites·11 claims
- 1092US8551984B2Aminopyrimidines as SYK inhibitorsALTMAN MICHAEL D·Filed 2010·Granted Oct 8, 2013·25 cites·40 claims
- 1189US10421765B2Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinaseUNIV TEXAS·Filed 2018·Granted Sep 24, 2019·7 cites·39 claims
- 1289US9216173B22-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitorsALTMAN MICHAEL D·Filed 2012·Granted Dec 22, 2015·8 cites·16 claims
- 1388US9663504B2Salts of heterocyclic modulators of HIF activity for treatment of diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2015·Granted May 30, 2017·6 cites·30 claims
- 1488US9120785B2Pyridyl aminopyridines as Syk inhibitorsALTMAN MICHAEL D·Filed 2012·Granted Sep 1, 2015·13 cites·13 claims
- 1588US8183216B2Nucleoside derivatives as inhibitors of viral polymerasesDI FRANCESCO MARIA EMILIA·Filed 2008·Granted May 22, 2012·28 cites·14 claims
- 1687US9290490B2Aminopyrimidines as Syk inhibitorsALTMAN MICHAEL D·Filed 2012·Granted Mar 22, 2016·12 cites·25 claims
- 1786US11400108B2Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signallingUNIV TEXAS·Filed 2020·Granted Aug 2, 2022·1 cites·24 claims
- 1886US10933078B2Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signallingUNIV TEXAS·Filed 2018·Granted Mar 2, 2021·2 cites·28 claims
- 1986US10800769B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2019·Granted Oct 13, 2020·2 cites·16 claims
- 2086US8178520B2Macrocyclic compounds as antiviral agentsDI FRANCESCO MARIA EMILIA·Filed 2007·Granted May 15, 2012·13 cites·20 claims
- 2186US2024360121A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2024·Application pending·0 cites
- 2285US2025041324A1Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signallingUNIV TEXAS·Filed 2024·Application pending·0 cites
- 2384US10745420B2Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinaseUNIV TEXAS·Filed 2019·Granted Aug 18, 2020·2 cites·26 claims
- 2484US8377873B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2007·Granted Feb 19, 2013·9 cites·16 claims
- 2582US10208059B2Heterocyclic modulators of HIF activity for treatment of diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2016·Granted Feb 19, 2019·3 cites·6 claims
- 2682US8927569B2Macrocyclic compounds as antiviral agentsHARPER STEVEN·Filed 2008·Granted Jan 6, 2015·8 cites·17 claims
- 2781US10363248B2Salts of heterocyclic modulators of HIF activity for treatment of diseaseUNIV TEXAS·Filed 2017·Granted Jul 30, 2019·2 cites·28 claims
- 2881US9145391B2Bipyridylaminopyridines as Syk inhibitorsDESCHENES DENIS·Filed 2012·Granted Sep 29, 2015·10 cites·13 claims
- 2980US12036231B2Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signallingUNIV TEXAS·Filed 2022·Granted Jul 16, 2024·0 cites·20 claims
- 3080US11001594B2Heterocyclic modulators of HIF activity for treatment of diseaseUNIV TEXAS·Filed 2018·Granted May 11, 2021·1 cites·12 claims
- 3177US11028083B2Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferasesUNIV TEXAS·Filed 2019·Granted Jun 8, 2021·1 cites·36 claims
- 3276US10800774B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2018·Granted Oct 13, 2020·2 cites·25 claims
- 3374US10894052B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2019·Granted Jan 19, 2021·1 cites·32 claims
- 3474US10888554B2Salts of heterocyclic modulators of HIF activity for treatment of diseaseUNIV TEXAS·Filed 2019·Granted Jan 12, 2021·0 cites·19 claims
- 3571US9487504B2Imidazolyl analogs as syk inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Nov 8, 2016·1 cites·7 claims
- 3670US2021137910A1Salts of heterocyclic modulators of hif activity for treatment of diseaseUNIV TEXAS·Filed 2020·Application pending·0 cites
- 3767US11434233B2Heterocyclic inhibitors of ATR kinaseUNIV TEXAS·Filed 2020·Granted Sep 6, 2022·0 cites·21 claims
- 3864US11725008B2Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferasesUNIV TEXAS·Filed 2021·Granted Aug 15, 2023·0 cites·13 claims
- 3964US2023416261A1Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferasesUNIV TEXAS·Filed 2023·Application pending·0 cites
- 4060US2019134032A1Glutaminase inhibitor therapyUNIV TEXAS·Filed 2018·Application pending·0 cites
- 4156US2014243290A1Aminopyrimidines as SYK InhibitorsALTMAN MICHAEL D·Filed 2014·Application pending·0 cites
- 4255US2010099695A1HCV NS3 Protease InhibitorsLIVERTON NIGEL J·Filed 2007·Application pending·0 cites
- 4354US2011306573A1Nucleoside derivatives as inhibitors of viral polymerasesAVOLIO SALVATORE·Filed 2009·Application pending·0 cites
- 4452US9598405B2Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 21, 2017·0 cites·14 claims
- 4551US2016058759A1Glutaminase inhibitor therapyUNIV TEXAS·Filed 2015·Application pending·0 cites
- 4641US2019135793A1Heterocyclic inhibitors of kdm5 for the treatment of diseaseUNIV TEXAS·Filed 2018·Application pending·0 cites
- 4740US2016002204A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
- 4835US2016002248A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
- 4929US2012010164A1Antiviral agentsSURNMA VINCENZO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Maria Emilia Di Francesco files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →